News and Industry Information

Acuamark Diagnostics, Announces Change to Its Board of Directors

July 23, 2020

July 22, 2020

Acuamark Diagnostics, Announces Change to Its Board of Directors

NEW YORK — July 21, 2020 — Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that focuses on developing innovative blood-based screening assays for reliable and cost-effective detection of early-stage cancer, today announced the appointment of William Gedale as its Executive Chairman. Mr. Gedale will replace Mr. Michael Gargano as Chairman of the Company.

Lhere

Leave a Reply

Your email address will not be published. Required fields are marked *

CURRENT AND PREVIOUS CLIENTS

Get Our Newsletter

Stay up to date with news and deals